Increased risk of hepatocellular carcinoma in viral hepatitis associated end-stage liver disease (ESLD).

被引：0
|
作者：
Perez, RG [1 ]
Zein, NN [1 ]
Steers, JL [1 ]
Wiesner, RH [1 ]
机构：
[1] MAYO CLIN & MAYO FDN,DEPT GASTROENTEROL & LIVER TRANSPLANTAT,ROCHESTER,MN 55905
来源：
HEPATOLOGY | 1997年 / 26卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：109 / 109
页数：1
相关论文
共 50 条
  • [31] Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons
    Ryom, Lene
    Lundgren, Jens Dilling
    De Wit, Stephane
    Kovari, Helen
    Reiss, Peter
    Law, Matthew
    El-Sadr, Wafa
    Monforte, Antonella D'Arminio
    Mocroft, Amanda
    Smith, Colette
    Fontas, Eric
    Dabis, Francois
    Phillips, Andrew
    Sabin, Caroline
    AIDS, 2016, 30 (11) : 1731 - 1743
  • [32] MELDEQ: An Alternative Model for End-Stage Liver Disease Score for Patients With Hepatocellular Carcinoma
    Marvin, Michael R.
    Ferguson, Nicole
    Cannon, Robert M.
    Jones, Christopher M.
    Brock, Guy N.
    LIVER TRANSPLANTATION, 2015, 21 (05) : 612 - 622
  • [33] High frequency of chronic end-stage liver disease and hepatocellular carcinoma in a Hispanic population
    Perez, A
    Anzaldua, M
    McCormick, J
    Fisher-Hoch, S
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (03) : 289 - 295
  • [34] Model for end-stage liver disease score predicts survival in patients with hepatocellular carcinoma
    Contreras, C. M.
    Behrens, J.
    Cho, C. S.
    Mahvi, D. M.
    Rikkers, L. F.
    Weber, S. M.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (02) : 96 - 96
  • [35] BURDENSOME TRANSITIONS OF CARE IN END-STAGE LIVER DISEASE (ESLD): A QUALITATIVE STUDY OF PATIENTS AND CAREGIVERS
    Ufere, Nneka
    Donlan, John
    Indriolo, Teresa
    Richter, James M.
    Thompson, Ryan
    Jackson, Vicki
    Volandes, Angelo
    Chung, Raymond T.
    Traeger, Lara
    El-Jawahri, Areej
    HEPATOLOGY, 2020, 72 : 424A - 424A
  • [36] Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease
    Tsui, Judith I.
    Vittinghoff, Eric
    Shlipak, Michael G.
    Bertenthal, Daniel
    Inadomi, John
    Rodriguez, Rudolph A.
    O'Hare, Ann M.
    ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (12) : 1271 - 1276
  • [37] Analysis of prognosis on patients with severe viral hepatitis using the model for end-stage liver disease
    Zhi-Hong Weng
    World Journal of Gastroenterology, 2005, (06) : 899 - 902
  • [38] Analysis of prognosis on patients with severe viral hepatitis using the model for end-stage liver disease
    Weng, Zhi-Hong
    Cai, Shu-Qing
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (06) : 899 - 902
  • [39] Type IIIb glycogen storage disease associated with end-stage cirrhosis and hepatocellular carcinoma
    Haagsma, EB
    Smit, GPA
    NiezenKoning, KE
    Gouw, ASH
    Meerman, L
    Slooff, MJH
    HEPATOLOGY, 1997, 25 (03) : 537 - 540
  • [40] Frequency of development of hepatocellular carcinoma and the utility of surveillance ultrasound examination in patients with END stage liver disease (ESLD) from hepatitis C cirrhosis on the liver transplantation waiting list
    Wieckowska, Anna
    Zein, Nizar N.
    GASTROENTEROLOGY, 2006, 130 (04) : A501 - A501
12345